β‐Blockers in Hypertension: A Reassessment of the Benefit of Combined α‐/β‐Blockade
- 1 April 2007
- journal article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 9 (s4) , 4-9
Abstract
β‐Blockers have a long history of use in patients with high blood pressure, either alone or in combination with other classes of antihypertensive agents. Although β‐blockers can lower blood pressure effectively, they have not been convincingly shown to reduce the likelihood of some cardiovascular complications from hypertension, and their utility for this purpose has been critically questioned of late. This growing distrust of β‐blocker therapy, however, is misguided. Negative sentiments about one drug in a class, as has been the case for atenolol, often become unfairly disparaging of all drugs in a class. In the process of such lumping, the heterogeneity of the various compounds making up a drug class is often neglected. Such is the case for combined α‐/β‐blockade, which is to be distinguished from β‐blockade alone because of differences in hemodynamic and metabolic effects. This should prompt a reappraisal of the role of selected agents, such as the combined α‐/β‐blocker carvedilol, in the long‐term treatment of hypertension.Keywords
This publication has 39 references indexed in Scilit:
- Controlled-Release Carvedilol: A Concluding PerspectiveThe American Journal of Cardiology, 2006
- Cardiovascular Risk Factors in Hypertension: Rationale and Design of Studies to Investigate the Effects of Controlled-Release Carvedilol on Regression of Left Ventricular Hypertrophy and Lipid ProfileThe American Journal of Cardiology, 2006
- Pharmacokinetic Properties of a New Controlled-Release Formulation of CarvedilolThe American Journal of Cardiology, 2006
- IntroductionThe American Journal of Cardiology, 2006
- Development of a Pharmacokinetic/Pharmacodynamic Model for Carvedilol to Predict β1-Blockade in Patients with Congestive Heart FailureThe American Journal of Cardiology, 2006
- Pharmacokinetic and Pharmacodynamic Comparison of Controlled-Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with HypertensionThe American Journal of Cardiology, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- β-blockers in hypertension: is carvedilol different?The American Journal of Cardiology, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trialsJACC, 1996